Severe Posterior Retinopathy of Prematurity: A Matched Cohort Analysis

Celine Chaaya1, Melissa Yuan1, Francisco Altamirano2

  • 1Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts.

Ophthalmology. Retina
|January 15, 2026
PubMed

Insights

Infants with severe retinopathy of prematurity (ROP) need treatment and often require it again. These infants also face increased risks of strabismus, amblyopia, and developmental delays.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Pediatrics

Background:

  • Severe posterior retinopathy of prematurity (ROP) is a significant cause of visual impairment in infants.
  • Treatment is often necessary for severe ROP, but outcomes and associated morbidities require further investigation.

Purpose of the Study:

  • To evaluate the treatment outcomes and long-term morbidities in infants with severe posterior ROP.
  • To compare the incidence of ocular and neurodevelopmental issues in treated severe ROP infants versus a control group.

Main Methods:

  • Retrospective cohort study comparing infants with severe posterior ROP requiring treatment to a matched cohort.
  • Data collection included treatment details, retreatment rates, and rates of strabismus, amblyopia, and developmental delay.

Main Results:

  • All infants with severe posterior ROP required initial treatment, with a high retreatment rate of 26.1%.
  • Compared to controls, infants with severe ROP exhibited significantly higher rates of strabismus, amblyopia, and developmental delay.

Conclusions:

  • Severe posterior ROP necessitates aggressive treatment and carries a substantial risk of recurrence or need for retreatment.
  • Infants treated for severe ROP face elevated risks for significant ocular comorbidities and neurodevelopmental challenges, underscoring the need for close monitoring.
Abstract

No abstract available in PubMed .